Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southpoint Capital Advisors is a New York-based investment management firm founded in 2004 by John S. Clark II. The firm operates as a hedge fund, employing a fundamental, research-intensive approach to long/short equity investing across various sectors, including healthcare, technology, and industrials. While not a biotechnology or pharmaceutical company itself, Southpoint is a prominent institutional investor within the healthcare sector, often taking significant positions in public life science companies. The firm is characterized by its disciplined, value-oriented strategy and concentrated portfolio management. It manages several billion dollars in assets for a variety of institutional clients and high-net-worth individuals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southpoint Capital Advisers.